5,960
Views
14
CrossRef citations to date
0
Altmetric
Review

Hepatitis A epidemiology in Latin American countries: a 2020 view from a systematic literature review

ORCID Icon, , , , &
Pages 795-805 | Received 31 Mar 2020, Accepted 14 Aug 2020, Published online: 21 Sep 2020

References

  • World Health Organization . The immunological basis for immunization series: module 18: hepatitis A. Geneva, Switzerland: World Health Organization; 2019. [accessed 2020 Jan 09]. Available from: https://www.who.int/immunization/documents/ISBN_978-92-51632-7/en/.
  • Jacobsen KH. Globalization and the changing epidemiology of hepatitis A virus. Cold Spring Harb Perspect Med. 2018;8(10):pii:a031716.
  • Ciocca M. Clinical course and consequences of hepatitis A infection. Vaccine. 2000;18(Suppl 1):S71–S74.
  • World Health Organization . WHO position paper on hepatitis A vaccines - June 2012. Wkly Epidemiol Rec. 2012;87(28/29):261–276.
  • Stanaway JD , Flaxman AD , Naghavi M , et al. The global burden of viral hepatitis from 1990 to 2013: findings from the global burden of disease study 2013. Lancet. 2016;388(10049):1081–1088.
  • Ozawa S , Privor-Dumm LA , Nanni A , et al. Evidence-to-policy gap on hepatitis A vaccine adoption in 6 countries: literature vs. policymakers’ beliefs. Vaccine. 2014;32(32):4089–4096.
  • Stapleton JT . Host immune response to hepatitis A virus. J Infect Dis. 1995;171(Suppl 1):S9–S14.
  • Mohd Hanafiah K , Jacobsen KH , Wiersma ST . Challenges to mapping the health risk of hepatitis A virus infection. Int J Health Geogr. 2011;10:57.
  • Tanaka J . Hepatitis A shifting epidemiology in Latin America. Vaccine. 2000;18(Suppl 1):S57–S60.
  • Van Effelterre T , Guignard A , Marano C , et al. Modeling the hepatitis A epidemiological transition in Brazil and Mexico. Hum Vaccin Immunother. 2017;13(8):1942–1951.
  • Atun R , de Andrade LO , Almeida G , et al. Health-system reform and universal health coverage in Latin America. Lancet. 2015;385(9974):1230–1247.
  • Liberati A , Altman DG , Tetzlaff J , et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.
  • Itani T , Jacobsen KH , Nguyen T , et al. A new method for imputing country-level estimates of hepatitis A virus endemicity levels in the Eastern Mediterranean region. Vaccine. 2014;32(46):6067–6074.
  • Koroglu M , Jacobsen KH , Demiray T , et al. Socioeconomic indicators are strong predictors of hepatitis A seroprevalence rates in the Middle East and North Africa. J Infect Public Health. 2017;10(5):513–517.
  • Stuurman AL , Marano C , Bunge EM , et al. Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines - A systematic review. Hum Vaccin Immunother. 2017;13(3):724–736.
  • United Nations Children’s Fund (UNICEF) and World Health Organization . Progress on drinking water, sanitation and hygiene 2000–2017. Special focus on inequalities. New York, USA: United Nations Children’s Fund (UNICEF) and World Health Organization; 2019. [accessed 2020 Jan 09]. Available from: https://www.who.int/water_sanitation_health/publications/jmp-report-2019/en/.
  • The World Bank . GNI per capita ranking, Atlas method and PPP based [Internet]. [2019; cited 2020 Jan 09]. Available from: https://datacatalog.worldbank.org/dataset/gni-capita-ranking-atlas-method-and-ppp-based
  • The World Bank . World Bank country and lending groups [Internet]. [2020; cited 2020 Jan 09]. Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups
  • Souto FJD , de Brito WI , Fontes CJF . Impact of the single-dose universal mass vaccination strategy against hepatitis A in Brazil. Vaccine. 2019;37(6):771–775.
  • Perazzo H , Pacheco AG , Luz PM , et al. Age-standardized mortality rates related to viral hepatitis in Brazil. BMC Infect Dis. 2017;17(1):527.
  • Linder KA , Malani PN . Hepatitis A. JAMA. 2017;318(23):2393.
  • Yanez LA , Lucero NS , Barril PA , et al. Evidence of hepatitis A virus circulation in central Argentina: seroprevalence and environmental surveillance. J Clin Virol. 2014;59(1):38–43.
  • Cervio G , Trentadue J , D’Agostino D , et al. Decline in HAV-associated fulminant hepatic failure and liver transplant in children in Argentina after the introduction of a universal hepatitis A vaccination program. Hepat Med. 2011;3:99–106.
  • Vizzotti C , Gonzalez J , Rearte A , et al. Single-dose universal hepatitis A immunization in Argentina: low viral circulation and high persistence of protective antibodies up to 4 years. J Pediatric Infect Dis Soc. 2015;4(4):e62–e67.
  • Campolmi I , Spinicci M , Mayaregua DR , et al. Seroprevalence of hepatitis A virus, hepatitis E virus, and Helicobacter pylori in rural communities of the Bolivian Chaco, 2013. Am J Trop Med Hyg. 2018;98(5):1275–1280.
  • Masuet-Aumatell C , Ma Ramon-Torrell J , Casanova-Rituerto A , et al. Prevalence of hepatitis A antibodies in Eastern Bolivia: a population-based study. J Med Virol. 2013;85(10):1692–1697.
  • Gandolfo GM , Ferri GM , Conti L , et al. Prevalencia de las infecciones de los virus A, B, C y E de la hepatitis en dos grupos de niños de nivel socioeconómico distinto de Santa Cruz, Bolivia [Prevalence of infections by hepatitis A, B, C and E viruses in two different socioeconomic groups of children from Santa Cruz, Bolivia]. Med Clin (Barc). 2003;120(19):725–727. Spanish.
  • Ciaccia MC , Moreira RC , Ferraro AA , et al. Epidemiological and serological aspects of hepatitis A among children and teenagers in the city of Santos: a cross-sectional study. Sao Paulo Med J. 2012;130(4):230–235.
  • Gomes MA , Ferreira Ade S , da Silva AA , et al. Hepatitis A: seroprevalence and associated factors among schoolchildren of Sao Luis (MA), Brazil. Rev Bras Epidemiol. 2011;14(4):548–555.
  • Mantovani SA , Delfino BM , Martins AC , et al. Socioeconomic inequities and hepatitis A virus infection in Western Brazilian Amazonian children: spatial distribution and associated factors. BMC Infect Dis. 2015;15:428.
  • Nunes HM , Do Carmo Pereira Soares M , Sarmento VP , et al. Soroprevalência da infecção pelos vírus das hepatites A, B, C, D e E em município da região oeste do Estado do Pará, Brasil [Seroprevalence of hepatitis A, B, C, D and E virus infection in a municipality in the western region of the State of Pará, Brazil]. Rev Pan-Amaz Saude. 2016;7(1):55–62. Portugese.
  • Nunes HM , Sarmento VP , Malheiros AP , et al. As hepatites virais: aspectos epidemiológicos, clínicos e de prevenção em municípios da Microrregião de Parauapebas, sudeste do estado do Pará, Brasil [Viral hepatitis: epidemiological, clinical and prevention aspects in municipalities of the Parauapebas Microregion, southeastern Pará, Brazil]. Rev Pan-Amaz Saude. 2017;8(2):31–37. Portugese.
  • Pereira TM , Mantovani SA , Branco FL , et al. Hepatitis A seroprevalence in preschool children in Assis Brazil, Acre, Brazil, in 2003 and 2010. Int Health. 2016;8(2):132–141.
  • Pinheiro RS , Araujo LA , Caetano KA , et al. Intermediate endemicity of hepatitis A virus infection in rural settlement projects of southwest Goiás, Brazil. Arq Gastroenterol. 2015;52(3):200–203.
  • Vitral CL , Ospina FL , Artimos S , et al. Declining prevalence of hepatitis A virus antibodies among children from low socioeconomic groups reinforces the need for the implementation of hepatitis A vaccination in Brazil. Mem Inst Oswaldo Cruz. 2012;107(5):652–658.
  • Miranda J , Valenzuela M , Hurtado C , et al. Decrease in seroprevalence of hepatitis A virus in Santiago, Chile: A decade-long comparison. Gastroenterol Hepatol. 2019;42(4):248–249.
  • Fix AD , Martin OS , Gallicchio L , et al. Age-specific prevalence of antibodies to hepatitis A in Santiago, Chile: risk factors and shift in age of infection among children and young adults. Am J Trop Med Hyg. 2002;66(5):628–632.
  • Ministerio de Salud (Chile) . Informe de situación epidemiológica de hepatitis A y viral sin especificación (CIE 10: B15 y B19). Semana Epidemiológica 1— 39 (01 de enero al 29 de septiembre). 2018. Spanish. [accessed 2020 Jan 09]. Available from: http://epi.minsal.cl/wp-content/uploads/2018/10/BET_HEPATITIS_OCTUBRE_2018.pdf
  • Rubio MDP , Castro J , Guz E , et al. Seroprevalencia de la Hepatitis A y la Varicela en Bogotá, Colombia [Seroprevalence of Hepatitis A and Varicella in Bogota, Colombia]. Revista Panamericana de Infectología. 2006;3. Spanish. Available from: https://encolombia.com/medicina/revistas-medicas/infectologia/voli-41/revistapanadeinfev4-1-investigaseroprevaha/.
  • Vega M , Alvarez C , Arango AE , et al. Frecuencia y distribución de anticuerpos positivos contra la hepatitis A [Frequency and distribution of positive antibodies against hepatitis A]. Acta Med Colomb. 2003;28(2):71–75. Spanish. Available from: http://www.actamedicacolombiana.com/anexo/articulos/02-2003-04.pdf.
  • Instituto Nacional de Salud (Colombia) . Boletín Epidemiológico Semanal. 2019. 1–3. Spanish. Available from: http://www.ins.gov.co/buscador-eventos/BoletinEpidemiologico/2019%20Bolet%C3%ADn%20epidemiol%C3%B3gico%20semana%207.pdf
  • Taylor ML , García Z , Holst I , et al. Seroprevalencia de los virus de la Hepatitis A y B en grupos etarios de Costa Rica [Seroprevalence of Hepatitis A and B viruses in Costa Rican age groups]. Acta Med Costarric. 2001;43(4):153–158. Spanish. Available from: http://www.scielo.sa.cr/scielo.php?script=sci_arttext&pid=S0001-60022001000400001&lang=en.
  • Ministerio de Salud (Costa Rica) . Análisis de Situación de Salud Costa Rica. 2014. p. 73. Spanish. Available from: https://www.ministeriodesalud.go.cr/index.php/vigilancia-de-la-salud/analisis-de-situacion-de-salud/2618-analisis-de-situacion-de-salud-en-costa-rica/file
  • Quintana A , Sanchez L , Larralde O , et al. Prevalence of antibodies to hepatitis E virus in residents of a district in Havana, Cuba. J Med Virol. 2005;76(1):69–70.
  • Torres C , Ulloa B , Pabón L , et al. Elevada sero-prevalencia de hepatitis A en estudiantes escolares de Quito [High sero-prevalence of hepatitis A in school students in Quito]. Rev Fac Cien Med (Quito). 2016;41(1):49–56. Spanish.
  • Lozano Puertas SV , Miñaca Rea DE Seroprevalenciade hepatitis viral tipo a en alumnos entre 16 y 18 años del Colegio “Capitàn Edmundo Chiriboga G.” de la ciudad de Riobamba, Provincia de Chimborazo en el periodo lectivo 2009 2010” [Seroprevalence of viral hepatitis in students between 16 and 18 years of age at the College “Capita Edmundo Chiriboga G.” in the city of Riobamba, Province of Chimborazo in the school period 2009 2010” - Thesis]. Ecuador: Universidad Nacional de Chimborazo; 2010. Spanish.
  • Alexandra LTP Determinación de niveles de inmunoglobulinas IgG contra hepatitis A en escolares menores de 15 años en el Colegio Josè Joaquìn Olmedo del cantón Cayambe diagnosticado por el método de ELISA, en el laboratorio de genètica de la facultad de ciencias médicas periodo 2014 [Determination of immunoglobulin IgG levels against hepatitis A in schoolchildren under the age of 15 at the Josè Joaquìn Olmedo College of the canton Cayambe diagnosed by the ELISA method, in the genetic laboratory of the faculty of medical sciences, period 2014 - Thesis]. Ecuador: Universidad Central del Ecuador; 2015. Spanish.
  • Guamán Zhunio D Determinación de hepatitis “A” IgM en niños de séptimo año de educación básica, de la escuela “Ciudad de Huaquillas” e identificación de factores de riesgo [Determination of hepatitis “A” IgM in seventh-year primary education children, in the school “Ciudad de Huaquillas” and identification of risk factors - Thesis]: Universidad Nacional de Loja, Ecuador; 2012. Spanish.
  • Chamba Salinas EF Hepatitis A y su relación con factores de riesgo, en niños de 8 a 10 años, en la Parroquia Nambacola [Hepatitis A and its relationship to risk factors, in children aged 8 to 10 years, in Nambacola Parish - Thesis]. Universidad Nacional de Loja, Ecuador; 2015. Spanish.
  • Ministerio de Salud (El Salvador) . Datos Epidemiológicos consolidados por grupos de edad y sexo. Semana 14-2019. 2019. Spanish. [accessed 2020 Jan 09]. Available from: http://www.salud.gob.sv/archivos/vigi_epide2018/edad_consolidado402018.pdf
  • Steinberg EB , Mendoza CE , Glass R , et al. Prevalence of infection with waterborne pathogens: a seroepidemiologic study in children 6–36 months old in San Juan Sacatepequez, Guatemala. Am J Trop Med Hyg. 2004;70(1):83–88.
  • Ministerio de Salud Pública y Asistencia Social (Guatemala) . Semepi. Boletín de la Semana Epideiológica. 2019. p. 6–7. Spanish. Available from: http://epidemiologia.mspas.gob.gt/files/Publicaciones%202019/Boletines%202019/BOLETIN_SEMEPI%20_11.pdf
  • Secretariat de Salud (Honduras) . Boletín Epidemiológico República de Honduras. 2019. p. 2 & 19. Available from: https://portalunico.iaip.gob.hn/portal/ver_documento.php?uid=NTA5NjY3ODkzNDc2MzQ4NzEyNDYxOTg3MjM0Mg
  • Brown MG , Lindo JF , King SD . Investigations of the epidemiology of infections with hepatitis A virus in Jamaica. Ann Trop Med Parasitol. 2000;94(5):497–502.
  • Lazcano-Ponce E , Conde-Gonzalez C , Rojas R , et al. Seroprevalence of hepatitis A virus in a cross-sectional study in Mexico: implications for hepatitis A vaccination. Hum Vaccin Immunother. 2013;9(2):375–381.
  • Lopez-Gatell H , Garcia-Garcia L , Echaniz-Aviles G , et al. Hepatitis A seroprevalence in adolescents and young adults in Mexico: A 2012 national health and nutrition survey analysis. Vaccine. 2018;36(52):8094–8099.
  • Mayorga Perez O , Brinkhof MW , Egger M , et al. Decreasing risk of hepatitis A infection in Leon, Nicaragua: evidence from cross-sectional and longitudinal seroepidemiology studies. PLoS One. 2014;9(2):e87643.
  • Ministerio de Salud (Panama) . Boletin epidemiologico semanal de eventos de notificación obligatoria. 2016. p. 3. Spanish. Available from: http://www.minsa.gob.pa/sites/default/files/publicacion-general/boletin_epidemiologico-_se_52_.pdf
  • Organización Panamericana de la Salud, Organización Mundial de la Salud, Pronasida Paraguay, et al . Plan estratégico nacional para la prevención y el control de las hepatitis virales [National strategic plan for the prevention and control of viral hepatitis]. 2018. p. 9. Spanish. Available from: https://www.paho.org/par/index.php?option=com_docman&view=download&category_slug=publicaciones-con-contrapartes&alias=585-plan-estrategico-nacional-para-la-prevencion-y-el-control-de-las-hepatitis-virales-2018-2022&Itemid=253
  • Hernández R , Chaparro E , Diaz C , et al. Frecuencia de hepatitis a en niños y adolescentes de cinco ciudades del Perú [Frequency of hepatitis A in children and adolescents from five cities of Peru]. Rev Peru Med Exp Salud Publica. 2015;32(3):499–503. Spanish.
  • Heriberto Hidalgo C , Reátegui MG , Rada LA . Prevalencia de hepatitis viral A y B y factores de riesgo asociados a su infección en la población escolar de un distrito de Huánuco - Perú [Prevalence of viral hepatitis A and B and risk factors associated with infection in the school population of a district of Huánuco - Peru]. Rev Peru Med Exp Salud Publica. 2002;19(1):5–9. Spanish.
  • Vildósola H , Colichón A , Rubio MP , et al. Prevalencia de anticuerpos contra hepatitis A (anti-HVA IgG) en una población de 01 a 39 años en Lima [Anti-HAV IgG prevalence in a population between 1 and 39 years old in Lima]. Rev Gastroenterol Peru. 2000;20(2):141–145. Spanish.
  • Montano Lotito AA , Barañano R , Lageard B , et al. Prevalencia de hepatitis A en niños de 2 a 14 años y en población laboral de 18 a 49 años en Montevideo, Uruguay [Prevalence of hepatitis A in children aged 2 to 14 years and in working populations 18 to 49 years old in Montevideo, Uruguay]. Rev Méd Urug. 2001;17(2):84–98. Spanish.
  • Quian J , Rüttimann R , Matrai L . Prevalencia de anticuerpos contra hepatitis A en una población de Montevideo, Uruguay [Prevalence of hepatitis A antibodies in a population in Montevideo, Uruguay]. Arch Pediatr Urug. 2005;76(3):222–227. Spanish.
  • Ministerio del Poder Popular para la Salud (Venezuela) . Boletín Epidemiológico, Resumen de la Situación Epidemiológica Nacional. 2016. p. 15. Spanish. Available from: https://www.ovsalud.org/descargas/publicaciones/documentos-oficiales/Boletin-Epidemiologico-2016.pdf
  • Krebs LS , Ranieri TM , Kieling CO , et al. Shifting susceptibility to hepatitis A among children and adolescents over the past decade. J Pediatr (Rio J). 2011;87(3):213–218.
  • Vitral CL , da Silva-nunes M , Pinto MA , et al. Hepatitis A and E seroprevalence and associated risk factors: a community-based cross-sectional survey in rural Amazonia. BMC Infect Dis. 2014;14:458.
  • Bryan JP , Reyes L , Hakre S , et al. Epidemiology of acute hepatitis in the Stann Creek District of Belize, Central America. Am J Trop Med Hyg. 2001;65(4):318–324.
  • Ministerio de Salud Publica (Ecuador) . Gaceta Epidemiológica Semanal No. 52. 2018. 13. Spanish. Available from: https://www.salud.gob.ec/wp-content/uploads/2013/02/GACETA-GENERAL-S52.pdf
  • Organización Panamericana de la Salud (Nicaragua) . Prevención y Control de Enfermedades. Análisis de Salud. Día Mundial contra la Hepatitis [Prevention and Control of Diseases. Health Analysis. World Day against Hepatitis]. p. 2–4. Spanish. Available from: https://www.paho.org/nic/index.php?option=com_docman&view=download&category_slug=datos-y-estadisticas&alias=651-boletin-informativo-sobre-hepatitis&Itemid=235
  • Berdasquera Corcho D , Galindo Santana BM , Gala González Á . Hepatitis viral A: seis años de vigilancia en Guanajay [Viral hepatitis A: six years of surveillance in Guanajay]. Rev Cubana Med Gen Integr. 2006;22(3). Spanish. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864-21252006000300001.
  • Blanco Hernández N , Julia García Milián A , Coutín Marie G . Hepatitis A en el área de salud; Mártires de Calabazar; 1989–2006 [Hepatitis A in a healthcare region; Mártires de Calabazar; 1989–2006]. Rev Cubana Hig Epidemiol. 2009;47(2). Spanish. Available from: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-30032009000200007&lang=en.
  • Aguiar P . Reporte Técnico de Vigilancia. Comportamiento Epidemiológico de la Hepatitis A en Cuba [Technical Surveillance Report. Epidemiological Behavior of Hepatitis A in Cuba]. 2004. Spanish. Available from: http://www.sld.cu/galerias/pdf/sitios/vigilancia/rtv0304.pdf
  • Vizzotti C , Gonzalez J , Gentile A , et al. Impact of the single-dose immunization strategy against hepatitis A in Argentina. Pediatr Infect Dis J. 2014;33(1):84–88.
  • Estripeaut D , Contreras R , Tinajeros O , et al. Impact of Hepatitis A vaccination with a two-dose schedule in Panama: results of epidemiological surveillance and time trend analysis. Vaccine. 2015;33(28):3200–3207.
  • Romero C , Perdomo V , Chamorro F , et al. Prevención de hepatitis A mediante vacunación en Uruguay (2005–2010) [Hepatitis A prevention through vaccination in Uruguay (2005–2010)]. Rev Méd Urug. 2012;28(2):115–122. Spanish.
  • Catalina Pírez M Logros del Programa Nacional de Inmunización de Uruguay [Achievements of Uruguay’s National Immunization Program] [Internet]. [2015; cited 2020 Jan 09]. Available from: http://www.chlaep.org.uy/descargas/jornadas/1.pdf
  • Vitral CL , Gaspar AM , Souto FJ . Epidemiological pattern and mortality rates for hepatitis A in Brazil, 1980–2002–a review. Mem Inst Oswaldo Cruz. 2006;101(2):119–127.
  • Kury CM , Pinto MA , Silva JP , et al. Hepatitis A seroprevalence in public school children in Campos dos Goytacazes, Rio de Janeiro State, Brazil, prior to the introduction of the hepatitis A universal childhood vaccination. Cad Saude Publica. 2016;32(11):e00175614.
  • Markus JR , Cruz CR , Maluf EM , et al. Seroprevalence of hepatitis A in children and adolescents. J Pediatr (Rio J). 2011;87(5):419–424.
  • Jacobsen KH , Wiersma ST . Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010;28(41):6653–6657.
  • United Nations . World urbanization prospects: The 2018 revision (ST/ESA/SER.A/420). New York: United Nations; 2019. [accessed 2020 Jan 09]. Available from: https://population.un.org/wup/Publications/Files/WUP2018-Report.pdf.
  • GBD 2017 SDG Collaborators . Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):2091–2138.
  • Patterson J , Abdullahi L , Hussey GD , et al. A systematic review of the epidemiology of hepatitis A in Africa. BMC Infect Dis. 2019;19(1):651.
  • Gripenberg M , Aloysia D’Cor N , L’Azou M , et al. Changing sero-epidemiology of hepatitis A in Asia Pacific countries: A systematic review. Int J Infect Dis. 2018;68:13–17.
  • World Health Organization . WHO vaccine-preventable diseases: monitoring system. 2019 global summary [Internet]. [2019; cited 2019 Dec 11]. Available from: http://apps.who.int/immunization_monitoring/globalsummary/schedules
  • Suwantika AA , Yegenoglu S , Riewpaiboon A , et al. Economic evaluations of hepatitis A vaccination in middle-income countries. Expert Rev Vaccines. 2013;12(12):1479–1494.